instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Safety report Product A and ongoing Ibuprofen use alongside Product A
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my sister Scott Murray to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Urgent adverse event Product A and physician suspects both Product A and Methotrexate
Dear Post-Marketing Surveillance Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A adverse event and Product B no current exposure report
Dear Patient Safety Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 37 year old female patient ini... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A reaction report with Product B concomitant medication
Dear Post-Marketing Surveillance Unit,
I am the Consultant Nephrologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and previous Product B therapy report
Dear Sir or Madam,
I am the Consultant Neurologist at a surgical day case unit group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 64 year old ma... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A reaction report with Product B maintained during event
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 37 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Safety report Product A and Product B excluded as cause
Dear Adverse Events Reporting Centre,
I am the Consultant Hepatologist at a womens health clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 38... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Adverse reaction report involving Product A and Metformin not implicated in adverse event
To Whom It May Concern,
I am writing as the caregiver for my elderly aunt Patricia Burns to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction report with Lisinopril unchanged during event onset
Dear Sir or Madam,
I am the Senior Consultant at a wound care centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 68 year old m... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A suspected reaction with suspect Product A with suspect Atorvastatin – formal report
Dear Patient Safety Team,
I am the Chief of Medicine at a private cardiology practice group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious ad... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Sir or Madam,
I am the Chief of Medicine at a faith-based hospital system and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where the treating physic... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A suspected adverse reaction with Lisinopril not implicated in adverse event
Dear Post-Marketing Surveillance Unit,
I am the Head of Pharmacy Services at a wound care centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to r... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Chief of Medicine at a respiratory medicine centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event wh... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected reaction with Product B stopped months ago – formal report
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 60 year old male ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as c... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A adverse event and both Product A and Methotrexate identified as suspect report
Dear Pharmacovigilance and Risk Management Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Medical Director at a community health partnership covering 12 clinics and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Safety report Product A and suspect Product B also implicated
To Whom It May Concern,
I am the Senior Consultant at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Safety report Product A and concomitant Product B exposure
Dear Patient Safety Team,
I am the Clinical Pharmacy Director at a university hospital department and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and Levothyroxine unchanged during event onset
Dear Pharmacovigilance Team,
I am the Clinical Pharmacy Director at a regional hospital trust and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. T... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Clinical Safety and Regulatory Affairs,
I am the Chief of Medicine at a Veterans Affairs medical centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A adverse event and Atorvastatin unchanged during event onset report
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction and Levothyroxine stable during Product A reaction formal notification
Dear Sir or Madam,
I am the Consultant Haematologist at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my mother Patricia Lopez to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction and Product B excluded as cause formal notification
Dear Drug Safety Department,
I am the Consultant Gastroenterologist at a Veterans Affairs medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Patient Safety Team,
I am the Consultant Endocrinologist at a metropolitan ambulance service medical liaison office and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction report with Lisinopril concomitant medication only
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 37 year old female patient initiat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Formal adverse event notification Product A with Product A and Omeprazole jointly suspected
Good morning,
I am the Consultant Neurologist at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Adverse event report Product A plus Product B discontinued prior to event
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 41 year old female patient on Product A for ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse event report Product A plus Product B historical exposure documented
Dear Adverse Events Reporting Centre,
I am the Clinical Pharmacy Director at a faith-based hospital system and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and concomitant Product B therapy
Dear Pharmacovigilance Team,
I am the Senior Nurse Practitioner at a childrens hospital outpatient department and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected reaction with both Product A and Methotrexate identified as suspect – formal report
To Whom It May Concern,
I am the Senior Consultant at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to rep... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Formal adverse event notification Product A with Product B excluded as cause
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 42 year old male patient on Product A for 20 weeks who presen... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Drug Safety Department,
I am the Director of Clinical Services at a pharmaceutical benefit manager and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A suspected reaction with dual drug reaction Product A and Amoxicillin – formal report
Dear Post-Marketing Surveillance Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A reaction report with Product B excluded as cause
Dear Sir or Madam,
I am the Consultant Haematologist at a chain of retail pharmacies and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 67 year old femal... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Medical Affairs and Drug Safety,
I am the Pharmacy Operations Manager at a large academic medical centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Global Safety Unit,
I am the Ward Nurse Manager at a large endocrinology centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus Product B historical exposure documented
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife John Johnson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experience... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Drug Safety Department,
I am the Consultant Hepatologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the tr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Adverse event report Product A plus Omeprazole continued without change
Dear Sir or Madam,
I am the Clinical Pharmacist at a womens health clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Suspected adverse event with Product A and Amoxicillin also suspected by physician
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Neurologist at a rural district hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Medical Director at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where the... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Sir or Madam,
I am the Consultant Neurologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse reaction report involving Product A and Product B concomitant medication
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 38 year old male patient on Product A for 12 weeks who de... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse event and physician suspects both Product A and Metformin report
Dear Adverse Events Reporting Centre,
I am the Consultant Dermatologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a se... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Urgent adverse event Product A and concomitant Product B therapy
Dear Pharmacovigilance Team,
I am the Consultant Neurologist at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A reaction and suspected Omeprazole co-reaction formal notification
Dear Drug Safety Department,
I am the Medical Director at a metropolitan ambulance service medical liaison office and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a seriou... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and concurrent Product B use
Dear Post-Marketing Surveillance Unit,
I am the Consultant Cardiologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with historical Product B use
To Whom It May Concern,
I am writing as the caregiver for my mother John Webb to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 38 year old male patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Suspected adverse event with Product A and Levothyroxine maintained as background medication
Dear Sir or Madam,
I am the Consultant Neurologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse reaction report involving Product A and Omeprazole concomitant medication only
Hi,
I am the Medical Director at a cancer centre network and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 38 year ol... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Safety report Product A and Product B historical exposure documented
To Whom It May Concern,
I am the Medical Director at a university hospital department and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A suspected adverse reaction with Product B discontinued prior to event
Dear Global Safety Unit,
I am writing as the caregiver for my husband Amanda Gomez to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 50 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Serious adverse event report Product A and ongoing Omeprazole use alongside Product A
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Gastroenterologist at a hepatology referral centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Serious adverse event report Product A and Product B excluded as cause
Good morning,
I am the Head of Pharmacy Services at a group of private outpatient clinics and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Nephrologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Sir or Madam,
I am writing as the caregiver for my sister Rachel Santos to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physician suspects bo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Urgent adverse event Product A and Amoxicillin stable during Product A reaction
Good morning,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 68 year old male patient started on Product A 5 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Serious adverse event report Product A and continued Product B administration
Dear Post-Marketing Surveillance Unit,
I am writing as the caregiver for my elderly aunt Kimberly Aguilar to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse event and Product A and Levothyroxine both implicated report
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as c... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Pharmacovigilance report Product A with previous Product B therapy
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Hepatologist at a surgical day case unit group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A reaction report with Product B implicated only as concomitant
Dear Drug Safety Department,
I am writing as the caregiver for my sister Patricia Brown to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 42 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction and suspect Product B also implicated formal notification
Dear Pharmacovigilance Team,
I am the Director of Clinical Services at a metropolitan ambulance service medical liaison office and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to r... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A suspected reaction with Product B stopped months ago – formal report
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my father Elizabeth Jackson to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse event notification for Product A with Product B ongoing without change
Hi,
I am the Consultant Rheumatologist at a rehabilitation and long-term care facility and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienc... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A reaction and Product B not currently administered formal notification
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 53 year old female pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Adverse event report Product A plus concomitant Levothyroxine therapy
Dear Sir or Madam,
I am the Clinical Nurse Specialist at an integrated care system and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 55 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction report with Product B no longer taken
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 48 year old female patient on Product A for 14 weeks who... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Safety report Product A and Metformin concomitant medication only
Dear Clinical Safety and Regulatory Affairs,
I am the Attending Physician at a faith-based hospital system and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Urgent adverse event Product A and previous Product B therapy
Dear Drug Safety Department,
I am the Consultant Gastroenterologist at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under my care.
I... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A suspected adverse reaction with continued Product B administration
Hi,
I am writing as the caregiver for my sister Nancy West to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 41 year old female patient on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and Amoxicillin continued without change
To Whom It May Concern,
I am writing as the caregiver for my sister Donna Grant to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 37 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Consultant Hepatologist at a large academic medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Product A reaction and suspect Product B also implicated formal notification
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects bo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Pharmacovigilance report Product A with Product B not suspected
Dear Global Safety Unit,
I am writing as the caregiver for my mother Jacob Reynolds to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 55 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction and Lisinopril unchanged during event onset formal notification
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 38 year old male patient on Pr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Global Safety Unit,
I am the Ward Nurse Manager at a gastroenterology clinic partnership and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse event ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Senior Nurse Practitioner at a faith-based hospital system and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Medical Director at a womens health clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event w... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A adverse event and Product B not suspected report
Dear Drug Safety Department,
I am the Consultant Nephrologist at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Endocrinologist at a metropolitan ambulance service medical liaison office and I am writing to formally report an adverse event involving a patient under my care.
I wish to re... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse reaction with concomitant Atorvastatin therapy
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my wife Samuel Rice to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 45 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Good morning,
I am the Consultant Haematologist at a community health partnership covering 12 clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse eve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected reaction with Metformin maintained as background medication – formal report
Good morning,
I am writing as the caregiver for my elderly aunt Shirley Castro to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Adverse event notification for Product A with ongoing Product B treatment
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 68 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Urgent adverse event Product A and Amoxicillin stable during Product A reaction
Dear Pharmacovigilance and Risk Management Team,
I am the Medical Director at an immunology and allergy clinic and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Pharmacovigilance report Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Clinical Pharmacy Director at a dialysis centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serio... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Adverse reaction report involving Product A and Product B stopped before symptoms began
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 50 year old female patient on Product A for 15 wee... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects bo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Safety report Product A and Metformin stable during Product A reaction
Dear Sir or Madam,
I am the Pharmacy Operations Manager at a dialysis centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A suspected adverse reaction with Omeprazole continued without change
Dear Regional Pharmacovigilance Lead,
I am the Attending Physician at a metropolitan ambulance service medical liaison office and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to r... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Suspected adverse event with Product A and Levothyroxine maintained as background medication
Dear Corporate Drug Safety Department,
I am the Clinical Pharmacist at a hepatology referral centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse event notification for Product A with historical Product B use
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my sister Victoria Torres to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Formal adverse event notification Product A with Product A and Amlodipine jointly suspected
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician sus... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with Product B prior use not relevant
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 55 year old female patient who was started o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Urgent adverse event Product A and suspected combined effect Product A and Amoxicillin
Dear Patient Safety Team,
I am writing as the caregiver for my wife Margaret Cooper to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Product A adverse reaction with Product B past use excluded
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 67 year old female pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Serious adverse event report Product A and ongoing Product B treatment
Good morning,
I am the Consultant Endocrinologist at a metropolitan ambulance service medical liaison office and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.